(Q24247391)

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

A multicentre randomized controlled trial of oral misoprostol and i.m. syntometrine in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Misoprostol for prevention of postpartum hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

A randomised controlled trial of misoprostol versus oxytocin in the active management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Oral misoprostol for third stage of labor: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Prophylactic intramyometrial carboprost tromethamine does not substantially reduce blood loss relative to intramyometrial oxytocin at routine cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Rectal misoprostol versus intravenous oxytocin for the prevention of postpartum hemorrhage after vaginal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

WHO multicentre randomised trial of misoprostol in the management of the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Side effects of oral misoprostol during the first 24 hours after administration in the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Misoprostol versus oxytocin in the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

The use of rectal misoprostol as active pharmacological management of the third stage of labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

The effect of prostaglandin F2∝ on third stage labor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Effect of oxytocics on prostaglandin levels in the third stage of labour

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

The misoprostal third stage study: a randomised controlled comparison between orally administered misoprostol and standard management. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stag

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Instability of (methyl)ergometrine in tropical climates: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

Trials to assess equivalence: the importance of rigorous methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2 alpha, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

Carboprost trometamol in the management of the third stage of labor

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

Uterine motility after post-partum application of sulprostone and other oxytocics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

The effects of intramyometrial injection of prostaglandin F2α on severe post-partum hemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

Absorption kinetics of misoprostol with oral or vaginal administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

PROPHYLACTIC USE OF 15(S)15 METHYL PGF2α BY INTRAMUSCULAR ROUTE FOR CONTROL OF POSTPARTUM BLEEDING - A COMPARATIVE TRIAL WITH METHYLERGOMETRINE.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

PROPHYLACTIC USE OF 15(S)15 METHYL PGF2α , BY INTRAMUSCULAR ROUTE - A CONTROLLED CLINICAL TRIAL.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

The circulating levels of oxytocin following intravenous and intramuscular administration of Syntometrine

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

A randomized comparison of oxytocin, sulprostone and placebo in the management of the third stage of labour

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

Use of oral misoprostol in the prevention of postpartum haemorrhage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

Misoprostol dose-related shivering and pyrexia in the third stage of labour. WHO Collaborative Trial of Misoprostol in the Management of the Third Stage of Labour.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

A randomized controlled study of prostaglandin 15-methyl F2 alpha compared with syntometrine for prophylactic use in the third stage of labour

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021

Preventing the recurrence of atonic postpartum hemorrhage: a double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000494.PUB2

7 January 2021